Blue Cross Sues Pfizer Over Off-Label Marketing

Law360, New York (June 9, 2010, 4:05 PM EDT) -- Health Care Service Corp. has accused Pfizer Inc. of bilking its Blue Cross Blue Shield health insurance plans out of millions of dollars by allegedly deceptively marketing Bextra, Geodon and Lyrica for off-label uses.

The pharmaceutical giant's actions caused BCBS plans in Texas, Illinois, New Mexico and Oklahoma to pay more money more often for the drugs, according to a complaint filed Friday in the U.S. District Court for the Eastern District of Texas.

The suit, which also targets Pfizer unit Pharmacia & Upjohn Inc. and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.